• Publications
  • Influence
PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma
The results suggest that PARP inhibition in combination with the alkylating agent dacarbazine could be of clinical interest for UM treatment. Expand
Effects of Dintrato(1,2-diaminocyclohexane)platinum (NSC 239851) On murine myeloma and hemopoietic precursor cells.
When marrow cells were exposed to NSC 239851 at 4 degrees in culture, almost total abrogation of the cytotoxicity was noted, which suggests that the transport of this agents is an active process. Expand